The article from RUV Frettir tackles a complex ethical question: whether human life can and should be assigned a financial value. This topic often arises in discussions about healthcare, insurance, and policy-making, where the costs of saving lives can reach astronomical figures, prompting debates about resource allocation and the value of saved lives. Economic theories sometimes suggest using metrics like Quality Adjusted Life Years (QALY) to guide healthcare spending, which raises further questions regarding morality and equity. The implications of assigning a monetary value to human life stretch far beyond healthcare—from how insurance companies operate to the value placed on lives in the context of legal settlements and corporate practices. By examining the intersection of economics, ethics, and human rights, the article aims to provide insight into why this question is so contentious, illustrating the broader impact of such valuations on society and individual lives.